SEP
Southland Equity Partners’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.23M | Sell |
28,183
-161
| -0.6% | -$29.9K | 1.15% | 21 |
|
|
2025
Q1 | $5.94M | Sell |
28,344
-101
| -0.4% | -$21.2K | 1.38% | 17 |
|
|
2024
Q4 | $5.05M | Buy |
28,445
+3,954
| +16% | +$703K | 1.18% | 21 |
|
|
2024
Q3 | $4.84M | Buy |
24,491
+6,736
| +38% | +$1.33M | 1.18% | 19 |
|
|
2024
Q2 | $3.05M | Buy |
17,755
+10,078
| +131% | +$1.73M | 0.87% | 27 |
|
|
2024
Q1 | $1.4M | Buy |
7,677
+1,481
| +24% | +$270K | 0.39% | 48 |
|
|
2023
Q4 | $960K | Sell |
6,196
-315
| -5% | -$48.8K | 0.3% | 55 |
|
|
2023
Q3 | $970K | Buy |
6,511
+137
| +2% | +$20.4K | 0.33% | 50 |
|
|
2023
Q2 | $859K | Buy |
6,374
+1,864
| +41% | +$251K | 0.29% | 55 |
|
|
2023
Q1 | $719K | Sell |
4,510
-43
| -0.9% | -$6.85K | 0.28% | 56 |
|
|
2022
Q4 | $736K | Buy |
4,553
+464
| +11% | +$75K | 0.28% | 53 |
|
|
2022
Q3 | $549K | Sell |
4,089
-188
| -4% | -$25.2K | 0.27% | 63 |
|
|
2022
Q2 | $655K | Buy |
4,277
+71
| +2% | +$10.9K | 0.3% | 59 |
|
|
2022
Q1 | $682K | Buy |
4,206
+5
| +0.1% | +$811 | 0.28% | 62 |
|
|
2021
Q4 | $569K | Buy |
4,201
+92
| +2% | +$12.5K | 0.23% | 76 |
|
|
2021
Q3 | $443K | Buy |
4,109
+153
| +4% | +$16.5K | 0.2% | 82 |
|
|
2021
Q2 | $446K | Buy |
3,956
+5
| +0.1% | +$563 | 0.21% | 83 |
|
|
2021
Q1 | $428K | Buy |
3,951
+176
| +5% | +$19K | 0.24% | 80 |
|
|
2020
Q4 | $404K | Buy |
+3,775
| New | +$404K | 0.27% | 72 |
|